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The tubby protein (Tub), a putative transcription factor, plays 
important roles in the maintenance and function of neuronal 
cells. A splicing defect-causing mutation in the 3’-end of the 
tubby gene, which is predicted to disrupt the carboxy-terminal 
region of the Tub protein, causes maturity-onset obesity, 
blindness, and deafness in mice. Although this pathological 
Tub mutation leads to a loss of function, the precise 
mechanism has not yet been investigated. Here, we found that 
the mutant Tub proteins were mostly localized to puncta 
found in the perinuclear region and that the C-terminus was 
important for its solubility. Immunocytochemical analysis 
revealed that puncta of mutant Tub co-localized with the 
aggresome. Moreover, whereas wild-type Tub was trans-
located to the nucleus by extracellular signaling, the mutant 
forms failed to undergo such translocation. Taken together, our 
results suggest that the malfunctions of the Tub mutant are 
caused by its misfolding and subsequent localization to 
aggresomes. [BMB Reports 2017; 50(1): 37-42]
INTRODUCTION
The tubby gene (TUB) was first identified from a spontaneous 
adult-onset obese mouse strain (called tubby mice), and other 
members of the TUB family were subsequently cloned in 
humans and mice (1-4). The members of the tubby-like protein 
(TULP) family share highly conserved signature carboxy- 
terminal (C-terminal) tubby domains, but vary in the sequences 
and functions of their amino (N) termini. TULPs (including 
Tub, TULP1, TULP2 and TULP3) are evolutionally conserved 
in various multicellular organisms from plants to humans. 
Their levels of gene expression in vertebrates are varied and 
highly regulated (5, 6), and mutations of TULP family 
members have been strongly associated with various diseases 
in mammals. A mutation of TULP1, which is selectively 
expressed in retina, causes retinitis pigmentosa in humans and 
retinal degeneration in mice (7-9), whereas loss of TULP3 
which is expressed ubiquitously in the mouse embryo, yields 
embryonic lethality with defects in the dorsoventral patterning 
of the spinal cord (10, 11). TUB is highly expressed in the 
brain, particularly in the hypothalamus, and tubby mice show 
deafness and blindness in addition to an obese phenotype. 
Tubby mice have been shown to carry a splice defect mutation 
in the 3’ coding region of TUB, leading to the generation of a 
longer transcript containing the unspliced introns, and the 
replacement of 44 C-terminal amino acids with an intron- 
encoded sequence (2, 3).
The C-terminal domain of Tub, which comprises the 
signature tubby domain, binds to phosphatidylinositol 4,5- 
bisphosphate (PIP2), thereby localizing the protein to the 
plasma membrane. Upon G-protein activation or insulin 
signaling, Tub translocates to the nucleus (12, 13). Boggon et 
al. have suggested that the C-terminus of Tub contains a DNA 
binding domain (DBD) (14), but we do not yet know the 
specific DNA sequence recognized by Tub or its trans-
criptionally activated targets. Moreover, although Stubdal et al. 
showed TUB knockout mice showed a phenotype identical to 
that of naturally arising tubby mice (15), it is unclear how the 
latter mutation leads to loss of function.
In this study, we manipulated mouse TUB-encoding 
constructs to produce wild-type, C-terminal-domain mutant, 
and C- and N-terminal-domain Tub proteins, and examined 
their expressions in the Neuro-2A mouse neuroblastoma cell 
line. Our results revealed that mutant Tub proteins localized to 
the perinucleus as puncta exhibited a structure different from 
that of wild-type, and was associated with aggresomes.
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Fig. 1. The C-terminal region of tubby is essential for its sub-
cellular localization. (A) Frozen sections of mouse hippocampus 
were subjected to immunohistochemical analysis using an anti- 
tubby antibody. (B) A schematic representation of the utilized 
GFP-fused wild-type tubby, mutant tubby, and truncated tubby 
proteins. Numbers indicate positions with respect to the amino 
acid sequence. (C) Representative fluorescence micrographs of 
COS-7 cells are expressing GFP-fused proteins. COS-7 cells were 
transfected with constructs encoding GFP-tagged tubby proteins. 
Twenty-four hours later, the cells were starved overnight, fixed, 
and visualized by confocal microscopy. Nuclei were visualized 
with propidium iodide (PI). Scale bars: 20 m. (D) At 48 h post- 
transfection, the cells were lysed and separated into Tx-100 
soluble (supernatant) and insoluble (pellet) fractions. The fractions 
and total lysates were analyzed by Western blotting using anti- 
GFP and anti-actin antibodies.
RESULTS AND DISCUSSION
C-terminal mutation of tubby induces its aggregation as 
Tx-100 insoluble puncta
The C-terminal core domain of the mouse Tub protein (about 
260 amino acids) forms a unique structure in which a central 
hydrophobic helix at the C-terminus transverses the interior of 
a closed 12-stranded -barrel (14). In tubby mice, a single 
nucleotide substitution (G → T) in the 3’ coding region of the 
TUB causes a splicing defect that replaces the 44 C-terminal 
amino acids of the wild-type protein with a new sequence of 
20 amino acids (3). This change might abrogate the 
hydrophobicity of the C-terminal central helix (data not 
shown), leading to a loss of function. However, no previous 
study has examined this mutant Tub protein with respect to its 
processing for protein maturation, its localization, or how its 
function might be interrupted.
We first used immunohistochemical analysis with an 
antibody against tubby to examine the distribution pattern of 
wild-type or mutant Tub proteins in the mouse brain. Mutant 
Tub proteins showed punctate expression in the hippocampal 
regions of tubby mouse brains, whereas wild-type Tub protein 
was evenly distributed in the hippocampal regions of normal 
mouse brains (Fig. 1A). To evaluate the cellular distribution 
patterns of the wild-type, mutant, N-terminal domain, and 
C-terminal domain Tub proteins, we obtained cDNA of Tub or 
mutant Tub from a wild-type or tubby mouse respectively, 
generated constructs in which they were fused with green 
fluorescent protein (GFP), expressed the recombinant proteins 
in COS-7 cells, and observed their localizations (Fig. 1B). 
Consistent with previous reports, wild-type Tub localized to 
both the plasma membrane and the nucleus, the N-terminal 
domain (the putative transcriptional-activation domain; TAD) 
localized to the nucleus, and the C-terminal domain 
(containing the DBD) localized to the plasma membrane (12). 
In contrast, mutant Tub exhibited a punctate distribution in the 
perinuclear region, as did fusion proteins with deletion of the 
C-terminal 44 amino acids and a mutant C-terminal domain 
(Fig. 1C). To further characterize the biochemical properties of 
the various Tub proteins, we investigated their solubilities in 
detergent-containing solution. After transfection for 48 h, the 
COS-7 cell extract was separated into Tx-100-soluble and 
-insoluble fractions. We found that the wild-type, N-terminal 
domain, and C-terminal domain-mutant Tub proteins localized 
to the Tx-100 soluble fraction, whereas the majority of the 
mutant, C-terminal-deleted, and C-terminal-domain-mutant 
proteins localized to the insoluble fraction. Similar patterns 
were observed using Flag- or His-tagged tubby proteins (Fig. 
S1). Taken together, these observations suggest that C-terminal 
region of the Tub protein is important for its proper folding 
and subcellular localization.
Mutant tubby forms aggresome-like structures
We investigated the subcellular localization of the mutant Tub 
protein with fusing fluorescent organelle markers. We found 
that the ER-Tracker signal partly overlapped with that of 
mutant Tub protein, while those of LysoTracker, MitoTracker, 
and GM130 (a Golgi marker) did not overlap (Fig. 2).
Misfolded proteins are typically degraded by the sophis-
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Fig. 2. Mutant tubby aggregates co-localize with Hsp70 (an aggresome
marker), but not with markers for lysosomes (LysoTracker), the ER 
(ER-Tracker), mitochondria (MitoTracker), or the Golgi apparatus 
(GM130). COS-7 cells expressing GFP-mutant tubby were fixed and 
stained. Scale bars: 20 m.
Fig. 3. Overexpression of mutant tubby leads to aggresome for-
mation. (A) COS-7 cells were transfected with GFP-mutant tubby. 
At 12, 24, 48, and 72 h post-transfection, the cells were fixed 
and imaged for GFP. (B) At 12 h post-transfection, the cells were 
incubated with or without 20 ng/ml nocodazole for 24 h and 
then imaged for GFP. Scale bars: 20 m.
ticated proteasomal system. An imbalance between the 
generation and clearance of misfolded proteins and the 
subsequent accumulation of insoluble protein aggregates has 
been strongly associated with neurodegenerative diseases, 
including Parkinson’s disease and Huntington’s disease (16). 
Numerous reports have shown that misfolded proteins 
produced under stress conditions or genetic mutation form 
aggregates, move to the perinuclear region along microtubules, 
and accumulate as a type of microtubule-dependent inclusion 
body that is called an “aggresome” (17, 18). Various proteins, 
such as histone deacetylase 6, parkin, ataxin-3, dynein 
complex motor, and ubiquilin-1 are involved in aggresome 
formation, and all major chaperones (e.g., Hsc70, Hsp40, 
Hsp70 and small Hsp family members) are ubiquitously 
associated with aggresomes. Immunofluorescence analyses 
indicated that aggresomes colocalize with -tubulin, vimentin, 
and chaperones, including Hsp70 (19, 20). Here, we assessed 
co-immunostaining with Hsp70 to examine whether mutant 
Tub proteins observed in the perinuclear region were localized 
in aggresomes. As shown in Fig. 2, Hsp70 did indeed 
colocalize with GFP-mutant tubby in the perinuclear region, 
indicating that the protein was associated with aggresomes.
To form an aggresome, small aggregations of misfolded 
proteins located throughout the cytoplasm are recruited to the 
dynein motor complex and transported along microtubules 
toward the perinucleus near the microtubule organizing center 
(MTOC) (17, 18). Therefore, we analyzed the cellular dis-
tribution of mutant Tub proteins over time. After COS-7 cells 
had been transfected with GFP-mutant tubby, we observed 
diffuse fluorescence signals at 12 h post-transfection, many 
small aggregates in the cytoplasm at 24 h, and the appearance 
of larger perinuclear accumulations (and the corresponding 
loss of diffuse fluorescence) at 48 h and 72 h (Fig. 3A).
Since the movement of protein aggregates to the perinuclear 
region is dependent on microtubules (20), microtubule in-
hibitors (e.g., nocodazole) can block aggresome formation. To 
determine whether microtubule disruption could prevent the 
formation of mutant Tub aggresomes, COS-7 cells expressing 
GFP-mutant tubby were treated with 20 ng/ml nocodazole at 
24 h post-transfection and then viewed at 48 h using confocal 
microscopy. While non-inhibitor-treated cells exhibited large 
perinuclear aggresome structures, nocodazole-treated cells 
displayed diffuse proteins and small cytoplasmic aggregates 
(Fig. 3B). These observations suggested that the aggregation of 
mutant Tub is microtubule-dependent.
Mutant tubby is not translocated to the nucleus in response to 
extracellular signals
The Tub protein localizes to the plasma membrane via the 
binding of its C-terminus to PIP2 and its association with the G 
protein, q. The activation of q by a G-protein coupled 
receptor (GPCR)-ligand releases Tub protein from the plasma 
membrane through the action of phospholipase C-beta 
(PLC-), resulting in the nuclear translocation of the Tub 
protein (12). Moreover, insulin and leptin can phosphorylate 
the Tub protein through their receptors, thereby also inducing 
the PLC- mediated nuclear translocation of Tub (13, 21).
To investigate the translocation of Tub or mutant Tub in 
response to extracellular signaling, we transfected Neuro-2A 
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Fig. 4. The C-terminal region of tubby is important for its nuclear 
translocation. Neuro-2A cells were transfected with vectors 
encoding GFP-tubby or GFP-mutant tubby, and grown for 24 h. 
After being starved for overnight, the cells were treated with 10 
M UTP, 100 nM BK, or 1 M insulin for 2 h, and the cellular 
localizations of wild-type and mutant tubby were observed under 
confocal microscopy. Scale bars: 20 m.
cells with vectors encoding GFP-tubby or GFP-mutant tubby 
and treated the cells with UTP, bradykinin (BK), or insulin (Fig. 
4). We found that GFP-tubby was localized predominantly to 
the plasma membrane under basal conditions, whereas 
treatment with 10 M UTP, 100 nM BK, or 1 M insulin 
strongly triggered the translocation of GFP-tubby to the 
nucleus. These results confirm that PLC is activated and PIP2 in 
Neuro-2A cells stimulated with these agents. In contrast, 
GFP-mutant tubby remained in the perinuclear region upon 
extracellular stimulation with these agents; it was not 
translocated to the nucleus, and thus would fail to function as 
a transcription factor.
The C-terminal region of the Tub protein is essential for the 
function of this protein, as identical phenotypes are associated 
with the C-terminal mutation of tubby mice and knockout of 
the Tub protein. However, to our knowledge, no previous 
study had examined Tub proteins carrying C-terminal mutations. 
Here, we reveal that mutant Tub proteins colocalized with 
aggresomes in the perinuclear region and failed to undergo 
nuclear translocation in response to extracellular signals. This 
might offer a mechanistic basis for the loss of function in the 
C-terminally mutated protein.
MATERIALS AND METHODS
Ethics statement
All experiments of the current study were performed following 
an animal protocol approved by the Institutional Animal Care 
and Utilization Committee (IACUC) of Ulsan National Institute 
of Science and Technology (UNIST).
Antibodies
The antibodies were obtained as follows: anti-tubby, anti-GFP, 
anti-actin, and the anti-goat IgG-TRITC secondary antibody 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti- 
GM130 from BD Biosciences (Palo Alto, CA, USA); anti- 
Hsp70 from Cell Signaling (Danvers, MA, USA); anti-Flag from 
Sigma (St. Louis, MO, USA); horseradish peroxidase-conjugated 
goat anti-rabbit IgG and goat anti-mouse IgA, IgM, and IgG 
from Kirkegaard & Perry Laboratories (Gaithersburg, MD, 
USA).
Animals and immunohistochemistry
Homozygous mutant tubby mice (tub/tub) were purchased 
from Jackson Laboratory (Bar Harbor, ME, USA) and bred with 
wild-type C57BL/6J (wt/wt) mice (SLC Inc., Seoul, Korea). The 
obtained heterozygous tubby mice (tub/wt) were used as 
breeding parents. Mouse strains were bred and housed in the 
Animal Research Facility at UNIST under specific pathogen- 
free conditions in accordance with the AAALAC International 
Animal Care Policy. Animals were maintained in a controlled 
12 h light-dark cycle at a temperature of 22oC ± 1oC and were 
given unrestricted access to food and water. All surgery was 
performed under chloral hydrate anesthesia, and all efforts 
were made to minimize suffering. All animals at the end of the 
experiment were sacrificed by cervical decapitation.
For immunohistochemistry, 10-week-old wild-type or tubby 
mice were anesthetized and perfused with PBS followed by 
4% paraformaldehyde (PFA)/PBS. The mice were sacrificed by 
cervical decapitation. The brains were removed and placed in 
a standard Cryomold (Sakura Finetek, Tokyo, Japan), which 
was then filled with optimum cutting temperature (OCT) 
compound (Tissue-Tek; Sakura Finetek) and placed in dry ice. 
Once preserved, the frozen tissue samples were stored at 
−80oC until analysis. For immunostaining, cryostat sections 
(10-m) were obtained from the frozen tumor blocks, fixed 
with 4% paraformaldehyde for 10 min, and washed three 
times with PBS for 3 min each. The tissue sections were 
blocked with 20% FBS, incubated for 2 h with the anti-tubby 
antibody, and then incubated for 1 h with the anti-goat 
IgG-TRITC secondary antibody. The tissue-bearing slides were 
mounted with mounting medium and examined under a 
confocal microscope (LSM 510 Meta; Zeiss, Oberkochen, 
Germany).
Construction of plasmids
The full-length coding sequences for tubby or mutant tubby 
were generated by reverse transcription-PCR (RT-PCR) of total 
RNAs from wild-type or tubby mouse brains. Fragments of 
tubby (N-term, C-term, C-deletion) and mutant tubby (mutant- 
C-term) were produced by PCR. To generate GFP-, FLAG-, and 
His×6 proteins, appropriate PCR products were cloned into 
the pEGFP-C1 (BD Biosciences), pCMV2-Flag (Sigma), and 
pRSET C (Invitrogen) vectors, respectively.
PCR was performed using the following specific primers: 
wild type tubby, (5’-CCCGAATTCTATGACTTCCAAGCCGCA 
TTCCGAC-3’) and Tub-R (5’-CCCGAATTCCTACTCGCAGGC 
CAGCTTGC-3’); for mutant tubby, Tub-F and Mut-R (5’- 
CCCGAATTCTCAGGGGATTGGGGGTGGGGTG-3’); for N- 
terminal-domain tubby, Tub-F and Ndom-R (5’-CCCGAATTCT 
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CAGACCTCAATATCCACTGGTGGC-3’); for C-terminal-domain 
tubby, Cdom-F (5’-CCCGAATTCTCAGGATCTAGAGGAGTT 
TGCAC-3’) and Tub-R; and for C-deletion mutant tubby, Tub-F 
and Cdel-R (5’-CCCGAATTCGTCATTGCCGTGGATCTGG-3’).
Cell culture and transfection
COS-7 and Neuro-2a cells (American Type Culture Collection) 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and anti-
biotics. The cells were grown in a humidified atmosphere 
containing 5% CO2. For transient expression of the various 
constructs, the cells were plated on 6-well plates or coverslips 
coated with 10 g/ml of poly-L-lysine and transfected using 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according 
to the manufacturer’s protocol.
Analysis of Triton X-100 soluble and insoluble fractions
COS-7 cells were transfected with GFP-tubby, GFP-tubby 
(mutant), GFP-tubby (C-deletion), GFP-tubby (N-term), or GFP- 
tubby (mutant-C-term). At 48 h post-transfection, the cells were 
washed with ice-cold PBS and lysed for 30 min on ice with 
200 l of Triton X-100 (Tx-100)-containing lysis buffer (20 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 
1% Tx-100) supplemented with a protease-inhibitor cocktail. 
Insoluble and soluble fractions were separated by centrifu-
gation at 13,000 g for 15 min at 4oC. Once the supernatant 
was removed to a fresh tube, the insoluble pellet was 
resuspended in 200 l of 1% SDS in lysis buffer and sonicated 
for 20 s with a microtip-sonicator. For comparison, total cell 
lysates were prepared by sonicating cells with 200 l of 1% 
SDS in lysis buffer. Equal volumes of each fraction were boiled 
for 5 min in SDS-PAGE sample buffer and analyzed by 
SDS-PAGE as previously described (22).
Immunofluorescence
Cells were grown on coverslips, transfected as described, 
rinsed four times with PBS, and then fixed for 20 min with 4% 
(w/v) paraformaldehyde. For direct fluorescence, the cells 
were washed, subjected to nuclear staining with propidium 
iodide (PI), and mounted with mounting medium. For indirect 
immunofluorescence, cells were permeabilized with 0.1% 
Tx-100 for 30 min, washed with PBS, blocked with 1% goat 
serum, and incubated with anti-GM130 or -Hsp70. The cells 
were then washed and incubated with a secondary antibody 
(anti-mouse TRITC for GM130 or anti-rabbit TRITC for HSP70), 
washed, and mounted as described above. Confocal images 
were acquired using a Zeiss LSM 510 Meta confocal 
microscope.
Staining of lysosomes, the ER, and mitochondria
COS-7 cells were seeded on glass coverslips, transfected with 
vectors encoding GFP-mutant tubby, and stained with 
LysoTracker Red DND-99 (100 nM; Invitrogen), ER-Tracker (1 
mM; Molecular Probes, Eugene, OR, USA), or MitoTracker 
Red CMXRos diluted in HBSS (500 mM; Invitrogen) at 37oC to 
detect lysosomes, ER, and mitochondria, respectively. After 30 
min, the cells were washed with PBS, fixed with 4% 
formaldehyde, washed with PBS, and mounted as described 
above. 
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